# Helen of Troy Limited

Type: Company (HELE)

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/helen-of-troy-limited
Canonical HTML page: https://getlegalbrief.com/entity/helen-of-troy-limited

## Timeline

- **2026-06-11**: Pomerantz announces class actions — Pomerantz issued press releases notifying investors of filed lawsuits and upcoming lead plaintiff deadlines.
- **2026-05-26**: Verra Mobility contract termination disclosure — Received Avis Budget Group termination notice effective Sep 2026; revised 2026 outlook downward; cost cuts planned. Stock crashed 70.57% to $3.85 on May 27.
- **2026-05-04**: GeneDx Q1 2026 results — Adjusted gross margin 74%→69%, FY revenue guide cut to $475–$490M from $540–$555M, and $31.3M impairment on Fabric Genomics. Stock drop implied.
- **2026-04-17**: Badger Meter Q1 2026 results — EPS of $0.93 missed by $0.26, revenue of $202.03M missed by $28.58M; utility water sales -10% YoY. Stock fell 24.13% to $115.54.
- **2026-03-19**: PicS Q4/FY 2025 results — Enhanced ECL calculation reclassified R$590M loans to Stage 3, causing R$88M ($17.56M) ECL increase. Stock fell 22.5% to $12.27.
- **2026-01-30**: PicS N.V. initial public offering — PicS sold approx. 22.9M shares at $19.00 per share on NASDAQ.
- **2025-10-09**: Helen of Troy Q2 2026 results — Quarterly sales down 8.9% YoY, adjusted EPS down 51%, with ongoing disruption warnings. Stock fell 25%.
- **2025-07-10**: Helen of Troy Q1 2026 results — Net sales down 11% YoY, adjusted EPS down nearly 60%, and $414.4M goodwill impairment. Stock fell nearly 23%.
- **2025-04-16**: GeneDx announces acquisition of Fabric Genomics — GeneDx agreed to acquire Fabric Genomics, an AI-driven genomic interpretation firm.
- **2024-07-09**: Helen of Troy Q1 2025 results — Reported 49% YoY decline in EPS and cut full-year revenue outlook by >20%. Stock fell nearly 28%.

## Recent coverage (1 stories)

### 5 Securities Class Actions Filed: Pomerantz Targets HELE, PICS, BMI, VRRM, WGS with August Deadlines
2026-06-15 03:29:18 · Sentiment: Negative · Impact: 6/10 · Sources: 6

Pomerantz LLP has filed suits against five public companies, alleging securities fraud following dramatic stock declines. With lead plaintiff deadlines in early August 2026, investors must act quickly to recover losses. The cases spotlight disclosure lapses in industries from consumer goods to biotech.
Full story: https://getlegalbrief.com/story/pomerantz-files-5-class-actions-august-deadlines

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.